Texas Heart Institute (THI) conducts research through clinical trials as part of our mission to improve heart health. The trials conducted at THI are designed to test the safety and effectiveness of innovative new treatments and medications for patients.
Innovative Technologies & Techniques is produced at THI and explores promising advances in medicine that aim to extend the life of cardiac patients and patients at risk for series heart and vascular conditions. In response to the evolving pandemic, emerging topics related to COVID-19 are featured in the special Cardiology in the Time of COVID-19 episodes.
WPW is a genetic condition but usually doesn’t get diagnosed until later in life. It can cause symptomatic arrhythmias and may rarely lead to syncope or sudden death. Treatment usually is catheter ablation which is curative in most cases.